Hæmofili kliniske forsøg i Texas
8 studier for Hæmofili søger deltagere på steder i Texas.
Byer i Texas
Officiel studietekst (engelsk)
TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies
- The University of Texas Southwestern Medical Center, Dallas
RekruttererObservationsstudie
6 Months · Alle køn · Opdateret 29. sep. 2026 · NCT07692217Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Dell Children's Medical Center of Central Texas, Austin
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 0 til 20 · Alle køn · Opdateret 21. aug. 2026 · NCT04278404ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Children's Blood and Cancer Center of Central Texas, Austin
- North Texas Hemophilia and Thrombosis Program - Pediatric Program / Center for Cancer & Blood Disorders, Dallas
- North Texas Comprehensive Hemophilia Treatment Center, Dallas
- og 3 flere
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 17. aug. 2026 · NCT04398628A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
- University of Texas - Southwestern Medical Center- Site Number : 8400015, Dallas
RekruttererFase 3
Alder 1 til 11 · Mænd · Opdateret 17. aug. 2026 · NCT07285460Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
- The University of Texas Health Science Center at San Antonio, San Antonio
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 2. jun. 2026 · NCT03695978Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
- UT Health San Antonio, San Antonio
RekruttererFase 4
Alder 12 og opefter · Kvinder · Opdateret 12. maj 2026 · NCT05936580Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
- UT Southwestern Medical Center, Dallas
RekruttererFase 4
Alder 12 og opefter · Mænd · Opdateret 12. maj 2026 · NCT05935358SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
- Gulf States Hemophilia and Thrombophilia Center-University of Texas Health Science Center @Houston, Houston
RekruttererFase 4
Alder 12 til 100 · Alle køn · Opdateret 12. jan. 2026 · NCT04647227Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.